chronic subdural hematoma

Diverse Readmission Profiles After Chronic Subdural Hematoma: Insights from Machine Learning Phenotyping

By MedXY 08/09/2026

Readmissions following chronic/subacute subdural hematoma hospitalizations are common and mostly nonsurgical, with varied clinical trajectories. Machine learning analysis reveals distinct patient clusters with unique readmission risks, underscoring the need for tailored postdischarge care and broader trial endpoints.

Neurology news Radiology

Middle Meningeal Artery Embolization with n-Butyl Cyanoacrylate: A New Standard for Chronic Subdural Hematoma Management?

By MedXY 07/03/2026

A multicenter randomized trial shows that middle meningeal artery embolization with n-butyl cyanoacrylate, adjunct to standard care, significantly reduces recurrence and reoperation rates in chronic subdural hematoma without increasing adverse events.

Clinical Updates General Surgery Neurology news

Long-Term Mortality, Cognition, and Quality of Life After Chronic Subdural Hematoma Surgery: A Comprehensive Review

By MedXY 06/24/2026

This review synthesizes evidence on the long-term survival, excess mortality, and health-related quality of life in patients after chronic subdural hematoma surgery, emphasizing sustained mortality risks and cognitive-physical deficits up to 10 years postoperatively.